Medtecs International Corporation Limited (SGX:546)
Singapore
· Delayed Price · Currency is SGD 0.1310
-0.0010 (-0.76%)
At close: Mar 27, 2025
SGXC:546 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 54.42 | 52.64 | 56.24 | 144.16 | 400.33 | Upgrade
|
| Revenue Growth (YoY) | 3.39% | -6.41% | -60.98% | -63.99% | 480.38% | Upgrade
|
| Cost of Revenue | 47.5 | 46.68 | 59.58 | 100.68 | 228.66 | Upgrade
|
| Gross Profit | 6.92 | 5.96 | -3.34 | 43.48 | 171.67 | Upgrade
|
| Selling, General & Admin | 35.23 | 30.95 | 29.73 | 27.47 | 35.46 | Upgrade
|
| Other Operating Expenses | -1.72 | - | - | - | - | Upgrade
|
| Operating Expenses | 33.51 | 30.95 | 29.73 | 27.47 | 35.46 | Upgrade
|
| Operating Income | -26.59 | -24.99 | -33.07 | 16.01 | 136.21 | Upgrade
|
| Interest Expense | -0.77 | -0.74 | -0.82 | -0.85 | -1.49 | Upgrade
|
| Interest & Investment Income | 1.46 | 1.43 | 0.91 | 0.03 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.04 | 0.83 | 0.03 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | 1.27 | 1.21 | 1.64 | 0.37 | Upgrade
|
| EBT Excluding Unusual Items | -25.93 | -23.07 | -30.94 | 16.86 | 135.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.41 | 0.35 | 0.17 | 0.06 | 0 | Upgrade
|
| Other Unusual Items | - | 0.21 | 0.04 | - | - | Upgrade
|
| Pretax Income | -23.52 | -22.52 | -30.65 | 16.92 | 135.09 | Upgrade
|
| Income Tax Expense | 0.14 | -0.03 | -1.39 | 0.41 | 3.37 | Upgrade
|
| Earnings From Continuing Operations | -23.66 | -22.49 | -29.26 | 16.51 | 131.72 | Upgrade
|
| Minority Interest in Earnings | 1.63 | 1.42 | 0.67 | 0.83 | -0.01 | Upgrade
|
| Net Income | -22.03 | -21.07 | -28.6 | 17.34 | 131.71 | Upgrade
|
| Net Income to Common | -22.03 | -21.07 | -28.6 | 17.34 | 131.71 | Upgrade
|
| Net Income Growth | - | - | - | -86.83% | 11234.85% | Upgrade
|
| Shares Outstanding (Basic) | 545 | 545 | 545 | 547 | 549 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 545 | 545 | 547 | 549 | Upgrade
|
| Shares Change (YoY) | - | -0.07% | -0.30% | -0.46% | - | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.05 | 0.03 | 0.24 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.05 | 0.03 | 0.24 | Upgrade
|
| EPS Growth | - | - | - | -86.77% | 11266.95% | Upgrade
|
| Free Cash Flow | -2.44 | -12.08 | -16.26 | 13.73 | 92.94 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.02 | -0.03 | 0.03 | 0.17 | Upgrade
|
| Dividend Per Share | - | - | - | 0.006 | 0.050 | Upgrade
|
| Dividend Growth | - | - | - | -88.07% | - | Upgrade
|
| Gross Margin | 12.72% | 11.32% | -5.93% | 30.16% | 42.88% | Upgrade
|
| Operating Margin | -48.86% | -47.47% | -58.80% | 11.11% | 34.02% | Upgrade
|
| Profit Margin | -40.47% | -40.02% | -50.84% | 12.03% | 32.90% | Upgrade
|
| Free Cash Flow Margin | -4.49% | -22.94% | -28.91% | 9.52% | 23.22% | Upgrade
|
| EBITDA | -22.21 | -20.76 | -29.78 | 19.69 | 140.17 | Upgrade
|
| EBITDA Margin | -40.80% | -39.44% | -52.95% | 13.66% | 35.01% | Upgrade
|
| D&A For EBITDA | 4.39 | 4.23 | 3.29 | 3.68 | 3.96 | Upgrade
|
| EBIT | -26.59 | -24.99 | -33.07 | 16.01 | 136.21 | Upgrade
|
| EBIT Margin | -48.86% | -47.47% | -58.80% | 11.11% | 34.02% | Upgrade
|
| Effective Tax Rate | - | - | - | 2.41% | 2.50% | Upgrade
|
| Advertising Expenses | - | - | - | 1.44 | 0.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.